Bullying Perpetration and Narcissistic Personality Traits across Adolescence: Joint Trajectories and Childhood Risk Factors

od Farrell, Ann H., Vaillancourt, Tracy
Wydane w Front Psychiatry (2020)

Flexibility and innovation in the FDA’s novel regulatory approval strategies for hematologic drugs

od Farrell, Ann T., Goldberg, Kirsten B., Pazdur, Richard
Wydane w Blood (2017)

Transient ischemic attacks: predictability of future ischemic stroke or transient ischemic attack events

od Gupta, Harsh V, Farrell, Ann M, Mittal, Manoj K
Wydane 2014

Effects of daily iron supplementation in primary-school–aged children: systematic review and meta-analysis of randomized controlled trials

od Low, Michael, Farrell, Ann, Biggs, Beverley-Ann, Pasricha, Sant-Rayn
Wydane 2013

Carbapenem Resistant Enterobacteriaceae and Endoscopy: An Evolving Threat

od O'Horo, John C., Farrell, Ann, Sohail, M. Rizwan, Safdar, Nasia
Wydane w Am J Infect Control (2016)

Prognostic significance of hepatic encephalopathy in patients with cirrhosis treated with current standards of care

od Bohra, Anuj, Worland, Thomas, Hui, Samuel, Terbah, Ryma, Farrell, Ann, Robertson, Marcus
Wydane w World J Gastroenterol (2020)

The NOURISH randomised control trial: Positive feeding practices and food preferences in early childhood - a primary prevention program for childhood obesity

od Daniels, Lynne A, Magarey, Anthea, Battistutta, Diana, Nicholson, Jan M, Farrell, Ann, Davidson, Geoffrey, Cleghorn, Geoffrey
Wydane 2009

Systematic Review with Meta-analysis: Recurrence of Crohn's disease after Total Colectomy with Permanent Ileostomy

od Fumery, Mathurin, Dulai, Parambir S., Meirick, Paul, Farrell, Ann M., Ramamoorthy, Sonia, Sandborn, William J., Singh, Siddharth
Wydane w Aliment Pharmacol Ther (2016)

FDA Approval Summary: Nivolumab for the Treatment of Relapsed or Progressive Classical Hodgkin Lymphoma

od Kasamon, Yvette L., de Claro, R. Angelo, Wang, Yaping, Shen, Yuan Li, Farrell, Ann T., Pazdur, Richard
Wydane w Oncologist (2017)

An appraisal of published usability evaluations of electronic health records via systematic review

od Ellsworth, Marc A, Dziadzko, Mikhail, O'Horo, John C, Farrell, Ann M, Zhang, Jiajie, Herasevich, Vitaly
Wydane w J Am Med Inform Assoc (2017)

Effects of Toxic Compounds in Montipora capitata on Exogenous and Endogenous Zooxanthellae Performance and Fertilization Success

od Hagedorn, Mary, Farrell, Ann, Carter, Virginia, Zuchowicz, Nikolas, Johnston, Erika, Padilla-Gamiño, Jacqueline, Gunasekera, Sarath, Paul, Valerie
Wydane w PLoS One (2015)

Survival of ethnic and racial minority patients with multiple myeloma treated with newer medications

od Pulte, E. Dianne, Nie, Lei, Gormley, Nicole, Goldberg, Kirsten B., McKee, Amy, Farrell, Ann, Pazdur, Richard
Wydane w Blood Adv (2018)

FDA Approval Summary: Lenalidomide as Maintenance Therapy After Autologous Stem Cell Transplant in Newly Diagnosed Multiple Myeloma

od Pulte, Elizabeth Dianne, Dmytrijuk, Andrew, Nie, Lei, Goldberg, Kirsten B., McKee, Amy E., Farrell, Ann T., Pazdur, Richard
Wydane w Oncologist (2018)

FDA Approval Summary: Temsirolimus as Treatment for Advanced Renal Cell Carcinoma

od Kwitkowski, Virginia E., Prowell, Tatiana M., Ibrahim, Amna, Farrell, Ann T., Justice, Robert, Mitchell, Shan Sun, Sridhara, Rajeshwari, Pazdur, Richard
Wydane 2010

In Reply

od Kwitkowski, Virginia E., Prowell, Tatiana M., Ibrahim, Amna, Farrell, Ann T., Justice, Robert, Sun Mitchell, Shan, Sridhara, Rajeshwari, Pazdur, Richard
Wydane 2010

FDA Approval Summary: Mylotarg for Treatment of Patients with Relapsed or Refractory CD33‐Positive Acute Myeloid Leukemia

od Norsworthy, Kelly J., Ko, Chia‐Wen, Lee, Jee Eun, Liu, Jiang, John, Christy S., Przepiorka, Donna, Farrell, Ann T., Pazdur, Richard
Wydane w Oncologist (2018)

U.S. Food and Drug Administration Benefit‐Risk Assessment of Nilotinib Treatment Discontinuation in Patients with Chronic Phase Chronic Myeloid Leukemia in a Sustained Molecular Re...

od Pulte, E. Dianne, Wroblewski, Tanya, Bloomquist, Erik, Tang, Shenghui, Farrell, Ann, Deisseroth, Albert, McKee, Amy E., Pazdur, Richard
Wydane w Oncologist (2019)

FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell‐Induced Severe or Life‐Threatening Cytokine Release Syndrome

od Le, Robert Q., Li, Liang, Yuan, Weishi, Shord, Stacy S., Nie, Lei, Habtemariam, Bahru A., Przepiorka, Donna, Farrell, Ann T., Pazdur, Richard
Wydane w Oncologist (2018)

FDA Supplemental Approval: Blinatumomab for Treatment of Relapsed and Refractory Precursor B‐Cell Acute Lymphoblastic Leukemia

od Pulte, E. Dianne, Vallejo, Jonathon, Przepiorka, Donna, Nie, Lei, Farrell, Ann T., Goldberg, Kirsten B., McKee, Amy E., Pazdur, Richard
Wydane w Oncologist (2018)

A Benefit-Risk Analysis Approach to Capture Regulatory Decision-Making: Multiple Myeloma

od Raju, G.K., Gurumurthi, Karthik, Domike, Reuben, Kazandjian, Dickran, Landgren, Ola, Blumenthal, Gideon M., Farrell, Ann, Pazdur, Richard, Woodcock, Janet
Wydane w Clin Pharmacol Ther (2017)